|

pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine Clinical Trials

1 actively recruiting trial across 1 location

Also known as: WOKVAC, WOKVAC Vaccine, pUMVC3-IGFBP2-HER2-IGF1R, pUMVC3-IGFBP2-HER2-IGF1R Vaccine

Pipeline

Phase 2: 1

Top Sponsors

  • University of Washington1

Indications

  • Anatomic Stage III Breast Cancer AJCC v81
  • Anatomic Stage II Breast Cancer AJCC v81
  • Anatomic Stage I Breast Cancer AJCC v81
  • Breast Cancer1
  • Cancer1

Seattle, Washington1 trial

Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer

Fred Hutch/University of Washington Cancer Consortium

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.